Alternative splicing and disease

被引:394
作者
Tazi, Jamal [2 ]
Bakkour, Nadia [2 ]
Stamm, Stefan [1 ]
机构
[1] Univ Kentucky, Coll Med, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA
[2] Univ Montpellier 2, Inst Mol Genet, CNRS, F-34095 Montpellier 5, France
来源
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE | 2009年 / 1792卷 / 01期
关键词
Alternative splicing; Disease; Splicing code; Mutation; SPINAL MUSCULAR-ATROPHY; COLI APC GENE; STERIC-BLOCK OLIGONUCLEOTIDES; AMYOTROPHIC-LATERAL-SCLEROSIS; TISSUE-SPECIFIC EXPRESSION; RNA SECONDARY STRUCTURE; MESSENGER-RNA; FRONTOTEMPORAL DEMENTIA; ALZHEIMERS-DISEASE; TAU GENE;
D O I
10.1016/j.bbadis.2008.09.017
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Almost all protein-coding genes are spliced and their majority is alternatively spliced. Alternative splicing is a key element in eukaryotic gene expression that increases the coding capacity of the human genome and an increasing number of examples illustrates that the selection of wrong splice sites causes human disease. A fine-tuned balance of factors regulates splice site selection. Here, we discuss well-studied examples that show how a disturbance of this balance can cause human disease. The rapidly emerging knowledge of splicing regulation now allows the development of treatment options. (C) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:14 / 26
页数:13
相关论文
共 191 条
[51]   SnoRNA Snord116 (Pwcr1/MBII-85) Deletion Causes Growth Deficiency and Hyperphagia in Mice [J].
Ding, Feng ;
Li, Hong Hua ;
Zhang, Shengwen ;
Solomon, Nicola M. ;
Camper, Sally A. ;
Cohen, Pinchas ;
Francke, Uta .
PLOS ONE, 2008, 3 (03)
[52]   Pre-mRNA splicing and human disease [J].
Faustino, NA ;
Cooper, TA .
GENES & DEVELOPMENT, 2003, 17 (04) :419-437
[53]   Quantitative analyses of SMN1 and SMN2 based on real-time LightCycler PCR:: Fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy [J].
Feldkötter, M ;
Schwarzer, V ;
Wirth, R ;
Wienker, TF ;
Wirth, B .
AMERICAN JOURNAL OF HUMAN GENETICS, 2002, 70 (02) :358-368
[54]  
Fischer DC, 2004, ONCOL REP, V11, P1085
[55]  
FORTH P, 2001, APOPTOSIS, V6, P463
[56]   Correction of aberrant splicing of the cystic fibrosis transmembrane conductance regulator (CFTR) gene by antisense oligonucleotides [J].
Friedman, KJ ;
Kole, J ;
Cohn, JA ;
Knowles, MR ;
Silverman, LM ;
Kole, R .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (51) :36193-36199
[57]   RNA and protein-dependent mechanisms in tauopathies: consequences for therapeutic strategies [J].
Gallo, J.-M. ;
Noble, W. ;
Martin, T. Rodriguez .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2007, 64 (13) :1701-1714
[58]   Cell motility is controlled by SF2/ASF through alternative splicing of the Ron protooncogene [J].
Ghigna, C ;
Giordano, S ;
Shen, HH ;
Benvenuto, F ;
Castiglioni, F ;
Comoglio, PM ;
Green, MR ;
Riva, S ;
Biamonti, G .
MOLECULAR CELL, 2005, 20 (06) :881-890
[59]  
Ghigna C, 1998, CANCER RES, V58, P5818
[60]   Ceramide-activated protein phosphatase involvement in insulin resistance via Akt, serine/arginine-rich protein 40, and ribonucleic acid splicing in L6 skeletal muscle cells [J].
Ghosh, Nilanjan ;
Patel, Niketa ;
Jiang, Kun ;
Watson, James E. ;
Cheng, Jin ;
Chalfant, Charles E. ;
Cooper, Denise R. .
ENDOCRINOLOGY, 2007, 148 (03) :1359-1366